GREENLAND MINES LTD Paid-in-Kind Interest
GREENLAND MINES LTD (GRML) reported Paid-in-Kind Interest of $1.61 thousand for the 3-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2026-08-17
- GREENLAND MINES LTD paid-in-kind interest for the quarter ending 2026-03-31 was $1.61K, a 99.70% decline year-over-year.
- GREENLAND MINES LTD paid-in-kind interest for the quarter ending 2025-12-31 was -$1.18M.
- GREENLAND MINES LTD paid-in-kind interest for the quarter ending 2025-09-30 was $1.22M.
- GREENLAND MINES LTD paid-in-kind interest for the quarter ending 2025-06-30 was $1.74M.
- GREENLAND MINES LTD paid-in-kind interest for fiscal 2025 was $2.33M, a 1542.09% increase from fiscal 2024.
- GREENLAND MINES LTD paid-in-kind interest for fiscal 2024 was $141.75K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.61K 10-Q/A · filed 2026-08-14 | -$1.18M derived: sum of 2 quarters · filed 2026-08-14 | $44.25K derived: sum of 3 quarters · filed 2026-08-14 | $1.78M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$1.18M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14 | $42.63K derived: sum of 2 quarters · filed 2026-08-14 | $1.78M derived: sum of 3 quarters · filed 2026-08-17 | $2.33M 10-K/A · filed 2026-08-14 |
| 2025-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.96M derived: sum of 2 quarters · filed 2026-08-17 | $3.51M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.74M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-17 | $2.29M 10-Q · filed 2026-08-17 | ||
| 2025-03-31 | $545.88K 10-Q/A · filed 2026-08-14 | |||
| 2024-12-31 | $141.75K 10-K/A · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |